Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Delafloxacin
1.2.3 Vancomycin
1.2.4 Ceftaroline Fosamil
1.2.5 Others
1.3 Market by Application
1.3.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cellulitis
1.3.3 Abscess
1.3.4 Surgical Wounds
1.3.5 Traumatic Wound
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Perspective (2018-2033)
2.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Growth Trends by Region
2.2.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Historic Market Size by Region (2018-2023)
2.2.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Region (2024-2033)
2.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Dynamics
2.3.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Industry Trends
2.3.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Drivers
2.3.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Challenges
2.3.4 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Revenue
3.1.1 Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Revenue (2018-2023)
3.1.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue
3.4 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Concentration Ratio
3.4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in 2022
3.5 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players Head office and Area Served
3.6 Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Solution and Service
3.7 Date of Enter into Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Breakdown Data by Type
4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Historic Market Size by Type (2018-2023)
4.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Type (2024-2033)
5 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Breakdown Data by Application
5.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Historic Market Size by Application (2018-2023)
5.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2018-2033)
6.2 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2018-2023)
6.4 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2018-2033)
7.2 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2018-2023)
7.4 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2018-2033)
8.2 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2018-2033)
9.2 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2018-2023)
9.4 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2018-2033)
10.2 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Furiex Pharmaceuticals, Inc.
11.1.1 Furiex Pharmaceuticals, Inc. Company Detail
11.1.2 Furiex Pharmaceuticals, Inc. Business Overview
11.1.3 Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.1.4 Furiex Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.1.5 Furiex Pharmaceuticals, Inc. Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Detail
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.2.4 GlaxoSmithKline plc Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 Melinta Therapeutics, Inc.
11.3.1 Melinta Therapeutics, Inc. Company Detail
11.3.2 Melinta Therapeutics, Inc. Business Overview
11.3.3 Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.3.4 Melinta Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.3.5 Melinta Therapeutics, Inc. Recent Development
11.4 Debiopharm International S.A.
11.4.1 Debiopharm International S.A. Company Detail
11.4.2 Debiopharm International S.A. Business Overview
11.4.3 Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.4.4 Debiopharm International S.A. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.4.5 Debiopharm International S.A. Recent Development
11.5 MerLion Pharmaceuticals Pte Ltd.
11.5.1 MerLion Pharmaceuticals Pte Ltd. Company Detail
11.5.2 MerLion Pharmaceuticals Pte Ltd. Business Overview
11.5.3 MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.5.4 MerLion Pharmaceuticals Pte Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.5.5 MerLion Pharmaceuticals Pte Ltd. Recent Development
11.6 Durata Therapeutics, Inc.
11.6.1 Durata Therapeutics, Inc. Company Detail
11.6.2 Durata Therapeutics, Inc. Business Overview
11.6.3 Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.6.4 Durata Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.6.5 Durata Therapeutics, Inc. Recent Development
11.7 Paratek Pharmaceuticals, Inc.
11.7.1 Paratek Pharmaceuticals, Inc. Company Detail
11.7.2 Paratek Pharmaceuticals, Inc. Business Overview
11.7.3 Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.7.4 Paratek Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.7.5 Paratek Pharmaceuticals, Inc. Recent Development
11.8 Cempra, Inc.
11.8.1 Cempra, Inc. Company Detail
11.8.2 Cempra, Inc. Business Overview
11.8.3 Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.8.4 Cempra, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.8.5 Cempra, Inc. Recent Development
11.9 Abbott Laboratories, Inc.
11.9.1 Abbott Laboratories, Inc. Company Detail
11.9.2 Abbott Laboratories, Inc. Business Overview
11.9.3 Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.9.4 Abbott Laboratories, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.9.5 Abbott Laboratories, Inc. Recent Development
11.10 Actelion Pharmaceuticals Ltd.
11.10.1 Actelion Pharmaceuticals Ltd. Company Detail
11.10.2 Actelion Pharmaceuticals Ltd. Business Overview
11.10.3 Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.10.4 Actelion Pharmaceuticals Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.10.5 Actelion Pharmaceuticals Ltd. Recent Development
11.11 Albany Molecular Research, Inc.
11.11.1 Albany Molecular Research, Inc. Company Detail
11.11.2 Albany Molecular Research, Inc. Business Overview
11.11.3 Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.11.4 Albany Molecular Research, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.11.5 Albany Molecular Research, Inc. Recent Development
11.12 Allergan plc.
11.12.1 Allergan plc. Company Detail
11.12.2 Allergan plc. Business Overview
11.12.3 Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.12.4 Allergan plc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.12.5 Allergan plc. Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Detail
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.13.4 AstraZeneca Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.13.5 AstraZeneca Recent Development
11.14 Bayer AG
11.14.1 Bayer AG Company Detail
11.14.2 Bayer AG Business Overview
11.14.3 Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.14.4 Bayer AG Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.14.5 Bayer AG Recent Development
11.15 Macrolide Pharmaceuticals, Inc.
11.15.1 Macrolide Pharmaceuticals, Inc. Company Detail
11.15.2 Macrolide Pharmaceuticals, Inc. Business Overview
11.15.3 Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.15.4 Macrolide Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.15.5 Macrolide Pharmaceuticals, Inc. Recent Development
11.16 Merck & Co, Inc.
11.16.1 Merck & Co, Inc. Company Detail
11.16.2 Merck & Co, Inc. Business Overview
11.16.3 Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.16.4 Merck & Co, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.16.5 Merck & Co, Inc. Recent Development
11.17 Pfizer, Inc.
11.17.1 Pfizer, Inc. Company Detail
11.17.2 Pfizer, Inc. Business Overview
11.17.3 Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.17.4 Pfizer, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.17.5 Pfizer, Inc. Recent Development
11.18 Sanofi
11.18.1 Sanofi Company Detail
11.18.2 Sanofi Business Overview
11.18.3 Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.18.4 Sanofi Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.18.5 Sanofi Recent Development
11.19 Teva Pharmaceuticals Industries Ltd.
11.19.1 Teva Pharmaceuticals Industries Ltd. Company Detail
11.19.2 Teva Pharmaceuticals Industries Ltd. Business Overview
11.19.3 Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.19.4 Teva Pharmaceuticals Industries Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.19.5 Teva Pharmaceuticals Industries Ltd. Recent Development
11.20 Zavante Therapeutics, Inc.
11.20.1 Zavante Therapeutics, Inc. Company Detail
11.20.2 Zavante Therapeutics, Inc. Business Overview
11.20.3 Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.20.4 Zavante Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
11.20.5 Zavante Therapeutics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Delafloxacin
Table 3. Key Players of Vancomycin
Table 4. Key Players of Ceftaroline Fosamil
Table 5. Key Players of Others
Table 6. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Region (2018-2023)
Table 10. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Region (2024-2033)
Table 12. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Trends
Table 13. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Drivers
Table 14. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Challenges
Table 15. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Restraints
Table 16. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Players (2018-2023)
Table 18. Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment as of 2022)
Table 19. Ranking of Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Solution and Service
Table 23. Date of Enter into Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Type (2024-2033)
Table 29. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Application (2024-2033)
Table 33. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 48. Furiex Pharmaceuticals, Inc. Company Detail
Table 49. Furiex Pharmaceuticals, Inc. Business Overview
Table 50. Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 51. Furiex Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 52. Furiex Pharmaceuticals, Inc. Recent Development
Table 53. GlaxoSmithKline plc Company Detail
Table 54. GlaxoSmithKline plc Business Overview
Table 55. GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 56. GlaxoSmithKline plc Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 57. GlaxoSmithKline plc Recent Development
Table 58. Melinta Therapeutics, Inc. Company Detail
Table 59. Melinta Therapeutics, Inc. Business Overview
Table 60. Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 61. Melinta Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 62. Melinta Therapeutics, Inc. Recent Development
Table 63. Debiopharm International S.A. Company Detail
Table 64. Debiopharm International S.A. Business Overview
Table 65. Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 66. Debiopharm International S.A. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 67. Debiopharm International S.A. Recent Development
Table 68. MerLion Pharmaceuticals Pte Ltd. Company Detail
Table 69. MerLion Pharmaceuticals Pte Ltd. Business Overview
Table 70. MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 71. MerLion Pharmaceuticals Pte Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 72. MerLion Pharmaceuticals Pte Ltd. Recent Development
Table 73. Durata Therapeutics, Inc. Company Detail
Table 74. Durata Therapeutics, Inc. Business Overview
Table 75. Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 76. Durata Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 77. Durata Therapeutics, Inc. Recent Development
Table 78. Paratek Pharmaceuticals, Inc. Company Detail
Table 79. Paratek Pharmaceuticals, Inc. Business Overview
Table 80. Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 81. Paratek Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 82. Paratek Pharmaceuticals, Inc. Recent Development
Table 83. Cempra, Inc. Company Detail
Table 84. Cempra, Inc. Business Overview
Table 85. Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 86. Cempra, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 87. Cempra, Inc. Recent Development
Table 88. Abbott Laboratories, Inc. Company Detail
Table 89. Abbott Laboratories, Inc. Business Overview
Table 90. Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 91. Abbott Laboratories, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 92. Abbott Laboratories, Inc. Recent Development
Table 93. Actelion Pharmaceuticals Ltd. Company Detail
Table 94. Actelion Pharmaceuticals Ltd. Business Overview
Table 95. Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 96. Actelion Pharmaceuticals Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 97. Actelion Pharmaceuticals Ltd. Recent Development
Table 98. Albany Molecular Research, Inc. Company Detail
Table 99. Albany Molecular Research, Inc. Business Overview
Table 100. Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 101. Albany Molecular Research, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 102. Albany Molecular Research, Inc. Recent Development
Table 103. Allergan plc. Company Detail
Table 104. Allergan plc. Business Overview
Table 105. Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 106. Allergan plc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 107. Allergan plc. Recent Development
Table 108. AstraZeneca Company Detail
Table 109. AstraZeneca Business Overview
Table 110. AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 111. AstraZeneca Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 112. AstraZeneca Recent Development
Table 113. Bayer AG Company Detail
Table 114. Bayer AG Business Overview
Table 115. Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 116. Bayer AG Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 117. Bayer AG Recent Development
Table 118. Macrolide Pharmaceuticals, Inc. Company Detail
Table 119. Macrolide Pharmaceuticals, Inc. Business Overview
Table 120. Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 121. Macrolide Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 122. Macrolide Pharmaceuticals, Inc. Recent Development
Table 123. Merck & Co, Inc. Company Detail
Table 124. Merck & Co, Inc. Business Overview
Table 125. Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 126. Merck & Co, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 127. Merck & Co, Inc. Recent Development
Table 128. Pfizer, Inc. Company Detail
Table 129. Pfizer, Inc. Business Overview
Table 130. Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 131. Pfizer, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 132. Pfizer, Inc. Recent Development
Table 133. Sanofi Company Detail
Table 134. Sanofi Business Overview
Table 135. Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 136. Sanofi Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 137. Sanofi Recent Development
Table 138. Teva Pharmaceuticals Industries Ltd. Company Detail
Table 139. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 140. Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 141. Teva Pharmaceuticals Industries Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 142. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 143. Zavante Therapeutics, Inc. Company Detail
Table 144. Zavante Therapeutics, Inc. Business Overview
Table 145. Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 146. Zavante Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023) & (US$ Million)
Table 147. Zavante Therapeutics, Inc. Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type: 2022 VS 2033
Figure 3. Delafloxacin Features
Figure 4. Vancomycin Features
Figure 5. Ceftaroline Fosamil Features
Figure 6. Others Features
Figure 7. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application: 2022 VS 2033
Figure 9. Cellulitis Case Studies
Figure 10. Abscess Case Studies
Figure 11. Surgical Wounds Case Studies
Figure 12. Traumatic Wound Case Studies
Figure 13. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Report Years Considered
Figure 14. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Region: 2022 VS 2033
Figure 17. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Players in 2022
Figure 18. Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in 2022
Figure 20. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Country (2018-2033)
Figure 22. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Country (2018-2033)
Figure 26. Germany Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Region (2018-2033)
Figure 34. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Country (2018-2033)
Figure 42. Mexico Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Country (2018-2033)
Figure 46. Turkey Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Furiex Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 49. GlaxoSmithKline plc Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 50. Melinta Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 51. Debiopharm International S.A. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 52. MerLion Pharmaceuticals Pte Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 53. Durata Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 54. Paratek Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 55. Cempra, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 56. Abbott Laboratories, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 57. Actelion Pharmaceuticals Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 58. Albany Molecular Research, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 59. Allergan plc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 60. AstraZeneca Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 61. Bayer AG Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 62. Macrolide Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 63. Merck & Co, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 64. Pfizer, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 65. Sanofi Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 66. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 67. Zavante Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed